Phase I study of trifluridine/tipiracil (TAS-102) plus irinotecan in combination with bevacizumab as a second-line therapy for patients with metastatic colorectal cancer
伊立替康
贝伐单抗
结直肠癌
医学
喜树碱
肿瘤科
化疗
内科学
药理学
癌症
化学
有机化学
作者
Jing Zhang,Wenwei Yang,Junbao Liu,Nan Wang,Zhaoying Ren,Tingting Yang,Gongli Xie,Guifu Wu,Yongkun Sun